viral
pathogen
emerg
human
last
centuri
thought
origin
variou
anim
speci
thu
zoonot
origin
mode
viral
dissemin
within
human
popul
gener
well
character
initi
step
interspeci
interfac
lead
viral
emerg
remain
poorli
understood
epidemiolog
field
studi
conduct
certain
specif
highrisk
popul
thu
crucial
obtain
new
insight
earli
event
emerg
process
human
infect
simian
virus
repres
increas
public
health
concern
inde
nonhuman
primat
nhp
consid
like
sourc
virus
infect
human
thu
may
pose
signific
threat
human
popul
well
illustr
retrovirus
abil
crossspeci
possibl
adapt
new
host
sometim
spread
within
new
speci
clear
emerg
human
immunodefici
viru
type
human
result
sever
independ
interspeci
transmiss
differ
siv
type
chimpanze
gorilla
western
part
central
africa
well
sooti
mangabey
west
africa
gave
rise
respect
probabl
first
part
last
centuri
similarli
origin
human
cell
lymphotrop
viru
type
subtyp
appear
link
interspeci
transmiss
monkey
human
follow
variabl
period
evolut
human
host
brief
review
present
current
avail
data
discoveri
crossspeci
transmiss
molecular
evolut
simian
foami
virus
sfv
present
differ
human
popul
risk
zoonot
emerg
sinc
initi
descript
foami
viru
fv
rhesu
monkey
kidney
cell
virus
isol
sever
anim
speci
includ
numer
nhp
speci
preval
fv
natur
infect
anim
gener
high
vari
wide
accord
speci
among
nhp
popul
sfv
seropreval
reach
adult
african
green
monkey
macaqu
oral
mucosa
tissu
import
site
viral
replic
explain
foami
viral
rna
found
high
concentr
saliva
primat
salivabas
mean
transmiss
bite
thu
strongli
suggest
infect
sfv
seem
caus
diseas
infect
nhp
studi
conduct
address
question
specif
howev
consid
coinfect
macaqu
sfv
increas
pathogen
simian
immunodefici
viru
first
human
foami
viru
isol
cell
cultur
kenyan
patient
suffer
nasopharyng
carcinoma
phylogenet
studi
demonstr
viru
origin
east
african
chimpanze
subspeci
pan
troglodyt
schweinfurtii
strain
consid
prototyp
foami
viru
pfv
howev
exact
origin
remain
unclear
vivo
crossspeci
transmiss
chimpanze
african
patient
cell
cultur
contamin
sever
paper
show
conflict
result
presenc
sfv
human
popul
differ
patient
find
reflect
high
percentag
nonspecif
serolog
reactiv
lack
specif
confirmatori
test
time
base
specif
serolog
molecular
assay
first
clear
evid
sfv
human
report
among
laboratori
monkey
hous
personnel
sinc
group
report
similar
find
seri
worker
occup
expos
nhp
usa
canada
recent
personnel
zoo
primat
center
gabon
china
infect
sfv
natur
set
demonstr
villag
cameroon
mostli
hunter
report
direct
contact
blood
andor
bodi
fluid
wild
nhp
extend
studi
differ
area
popul
central
african
countri
found
presenc
sfv
infect
least
person
great
major
bantu
pygmi
men
bitten
ape
mostli
gorilla
also
chimpanze
small
monkey
mostli
cercopithecu
nictitan
hunt
activ
recent
report
gabon
confirm
frequent
crossspeci
transmiss
hunter
sever
bite
mostli
gorilla
infect
women
also
recent
found
democrat
republ
congo
south
southeast
asian
countri
sfv
zoonot
infect
also
detect
variou
context
interspeci
contact
includ
monkey
templ
worker
pet
owner
peopl
live
around
freerang
macaqu
south
southeast
asia
interest
note
humannhp
interfac
asia
differ
greatli
africa
human
macaqu
sympatri
southeast
asia
date
back
far
year
humanmacaqu
commens
frequent
mani
monkey
templ
region
year
put
larg
number
person
includ
tourist
risk
macaqu
bite
inde
human
subject
south
asian
countri
came
contact
rhesu
macaqu
mostli
context
daili
live
share
geograph
area
home
rang
primat
popul
frequent
interact
lead
possibl
viral
interspeci
transmiss
situat
differ
central
africa
bushmeat
hunt
includ
ape
gorilla
chimpanze
major
risk
factor
associ
sfv
interspeci
transmiss
furthermor
central
africa
number
contact
human
mostli
hunter
wive
butcher
potenti
infect
nhp
probabl
greatli
increas
last
centuri
believ
due
increas
hunt
activ
result
combin
urban
demand
bushmeat
greater
access
nhp
habitat
provid
part
log
road
easier
access
fire
arm
increas
popul
live
forest
area
associ
increas
local
food
need
nowaday
human
consid
natur
host
sfv
case
sfv
infect
report
far
individu
close
contact
nhp
among
specif
patholog
yet
demonstr
howev
select
bia
inher
enrol
healthi
person
perform
studi
greatli
limit
current
abil
identifi
potenti
associ
diseas
sfv
genom
compris
retrovir
gag
pol
env
gene
two
regulatori
gene
ta
bet
intern
promot
allow
basal
transcript
ta
bet
figur
transactiv
ta
activ
second
promot
locat
longtermin
repeat
induc
synthesi
gag
pol
env
structur
protein
sfv
also
go
late
revers
transcript
step
releas
sfv
particl
thu
sfv
particl
contain
sfv
rna
sfv
dna
genom
figur
emerg
virus
interspeci
transmiss
vitro
sfv
infect
cell
type
heparan
sulfat
repres
attach
factor
howev
sfv
receptor
yet
discov
probabl
ubiquit
product
infect
cell
usual
form
syncitia
foamlik
cytopath
effect
cell
death
occur
figur
howev
cell
line
well
primari
cell
myeloid
lymphoid
lineag
remain
chronic
infect
nhp
sfv
latent
blood
cell
replic
superfici
epitheli
layer
oral
mucosa
explain
mode
transmiss
sfv
human
mainli
bite
viral
genom
buccal
swab
usual
reflect
found
blood
human
sfv
also
present
pbmc
saliva
howev
activ
replic
monitor
sfv
rna
detect
pbmc
saliva
blood
cellular
target
sfv
remain
poorli
studi
preliminari
studi
perform
mostli
small
seri
chimpanze
african
green
monkey
human
shown
sfv
dna
lymphocyt
especi
cell
studi
larger
cohort
human
infect
gorilla
strain
sfv
cameroon
demonstr
cell
b
lymphocyt
preferenti
infect
compar
monocyt
nk
cell
tabl
sfv
dna
detect
memori
naiv
lymphocyt
sfv
dna
level
cell
posit
correl
durat
infect
sfv
genom
display
high
evolutionari
conserv
among
speci
infect
sfv
genet
variabl
within
one
infect
anim
low
time
variat
year
genet
stabil
might
explain
long
coevolut
host
subsequ
effici
adapt
sfv
genet
stabil
could
also
prevent
delay
infect
new
host
molecular
chang
may
requir
infect
cell
differ
speci
andor
evad
hostspecif
immun
respons
genet
stabil
also
found
sfvinfect
human
less
diverg
nucleotid
sequenc
sever
year
sever
group
also
report
genet
modif
includ
mutat
bet
accessori
gene
delet
sequenc
ltr
improv
fv
replic
vitro
delet
ta
sequenc
might
link
chronic
infect
howev
modif
unifi
trait
zoonot
strain
also
found
nhp
experiment
infect
anim
suggest
viral
strain
remain
mainli
stabl
even
decad
crossspeci
transmiss
probabl
relat
appar
low
level
sfv
replic
infect
human
could
link
effici
immun
control
observ
sfv
sfvinfect
cell
cell
infect
chimpanze
sfv
strain
isol
sfvinfect
hunter
larg
syncytium
foami
aspect
visibl
use
light
microscopi
immunofluoresc
stain
perform
previous
describ
sfv
antigen
reveal
green
channel
nuclei
stain
dapi
b
transactiv
ta
activ
second
promot
locat
longtermin
repeat
induc
synthesi
gag
pol
env
structur
protein
assembl
viral
particl
bud
essenti
endoplasm
reticulum
late
reversetranscript
step
give
rise
dna
rna
particl
b
sfv
detect
plasmacytoid
dendrit
cell
exclus
trigger
ifni
product
sever
antivir
factor
induc
ifni
activ
sfv
antivir
protein
prevent
sfv
decapsid
apolipoprotein
bedit
catalyt
polypeptidelik
subunit
apobec
enzym
act
neg
strand
dna
produc
viral
revers
transcriptas
result
gtoa
mutat
viral
genom
potenti
deleteri
consequ
fv
bet
protein
shown
partial
prevent
apobec
action
nmyc
interactor
nmi
well
member
interferoninduc
protein
ifp
famili
inhibit
replic
prototyp
bovin
fv
respect
direct
interact
viral
transactiv
ta
tetherin
known
block
mani
differ
type
envelop
virus
tether
bud
viru
cell
membran
also
effici
prevent
fv
releas
virolog
wwwsciencedirectcom
origin
evolut
innat
immun
control
simian
foami
virus
human
rua
gessain
tabl
sfv
tropism
viral
load
blood
sfvinfect
human
nhp
proport
sfv
dna
posit
sampl
among
leukocyt
popul
sfvinfect
nhp
sfvinfect
human
indic
infect
strain
hum
sfvgor
nb
sfv
dna
samplesind
test
nt
sfv
dna
copiesnumb
cell
quantit
pcr
sfv
cell
sfv
cell
sfv
cell
sfv
cell
sfv
cell
na
agm
african
green
monkey
cpz
chimpanze
hum
human
nt
test
nb
number
ind
individu
na
applic
strain
close
studi
von
laer
et
al
popul
test
actual
lymphocyt
thu
like
enrich
b
nk
lymphocyt
proport
posit
sampl
agm
cpz
human
sfv
dna
load
sort
cell
popul
cell
posit
sampl
agm
cell
sampl
cpz
b
studi
callahan
et
al
one
dilut
leucocyt
dna
shown
correspond
viral
load
sfv
dna
cell
assum
usual
sensit
sfv
dna
cell
current
opinion
virolog
vivo
superinfect
recombin
sfv
group
report
case
coinfect
two
differ
sfv
ape
monkey
well
human
chimpanze
infect
sfvcpz
strain
coinfect
sfv
colobu
monkey
cercopithecu
monkey
frequent
chimpanze
macaqu
harbor
distinguish
sfvcpz
sfvmac
strain
respect
like
result
multipl
independ
infect
accumul
age
sfvcpz
infect
appear
first
occur
via
vertic
transmiss
follow
adult
life
acquisit
infect
possibl
stem
aggress
interact
studi
well
recent
one
sfv
appear
recombin
strain
other
found
differ
clone
sfv
singl
individu
suggest
coinfect
multipl
sfv
strain
whether
acquir
singl
time
sever
contact
nhp
known
interferon
potent
antivir
molecul
usual
repres
one
first
line
defens
pathogen
vitro
sfv
first
thought
low
interferoninduc
actual
depend
cell
type
inde
found
sfv
effici
sens
human
hematopoiet
cell
induc
product
high
level
ifni
main
produc
ifni
blood
plasmacytoid
dendrit
cell
detect
sfv
genom
uptak
sfv
particl
endosom
tolllik
receptor
cultur
system
addit
type
ifn
impair
sfv
replic
suggest
interferoninduc
gene
might
involv
control
sfv
replic
figur
b
apolipoprotein
bedit
catalyt
polypeptidelik
subunit
apobec
enzym
famili
antivir
cytidin
deaminas
act
neg
strand
dna
produc
viral
revers
transcriptas
result
gtoa
mutat
viral
genom
potenti
deleteri
consequ
howev
virus
often
produc
protein
counteract
cellular
defens
system
fv
bet
protein
shown
prevent
apobec
action
despit
action
bet
report
sfv
genom
found
human
display
gtoa
mutat
matsen
et
al
found
frequenc
type
hypermut
differ
human
macaqu
major
hypermut
lead
stop
codon
human
suggest
activ
restrict
infect
strain
human
passiv
acquisit
previous
mutat
strain
addit
studi
perform
vitro
elucid
mechan
involv
control
sfv
replic
although
relev
vivo
test
far
two
homolog
protein
nmyc
interactor
nmi
well
member
interferoninduc
protein
ifp
famili
inhibit
replic
pfv
bfv
respect
direct
interact
viral
transactiv
ta
tetherin
known
block
mani
differ
type
envelop
virus
tether
bud
viru
cell
membran
also
effici
prevent
fv
releas
antivir
protein
prevent
viral
decapsid
act
speciesspecif
manner
pfv
sfvmac
restrict
new
world
monkey
primat
includ
human
indic
probabl
involv
restrict
sfv
crossspeci
transmiss
chimpanze
macaqu
human
least
nowaday
note
known
antiretrovir
factor
potent
sfv
instanc
revers
transcript
occur
predominantli
entri
target
cell
virus
resist
dntp
level
reduct
studi
address
question
adapt
immun
respons
sfv
first
neutral
antibodi
present
serum
infect
anim
inhibit
sfv
transmiss
infect
rhesu
macaqu
indic
role
adapt
immun
respons
control
sfv
vivo
support
fact
antibodi
titer
fece
chimpanze
infect
sfv
invers
correl
sfv
viral
load
howev
data
avail
concern
adapt
immun
respons
sfv
human
antibodi
sfv
detect
blood
infect
individu
also
found
saliva
urin
sampl
four
sfvinfect
individu
test
howev
antibodi
titer
lower
infect
chimpanze
could
link
lower
level
sfv
replic
human
neutral
sfv
sera
three
sfvagminfect
individu
report
secondli
neutral
ifngamma
activ
pbmc
infect
sfv
increas
viral
express
sfv
upregul
mhci
vitro
suggest
adapt
immun
might
elicit
effici
control
sfv
infect
individu
although
virusspecif
lymphocyt
key
effector
control
outcom
htlv
hiv
infect
report
address
presenc
sfvinfect
nhp
human
human
infect
sfv
constitut
uniqu
natur
model
studi
variou
paramet
involv
restrict
retrovir
emerg
futur
sfv
emerg
human
remain
open
question
howev
current
increas
nhptohuman
contact
part
due
hunt
activ
anim
handl
may
favor
crossspeci
transmiss
furthermor
factor
sfv
coinfect
hiv
alreadi
report
cameroon
may
increas
risk
sfv
pathogen
requir
investig
nevertheless
predict
concern
viral
emerg
remain
difficult
hazard
recent
exemplifi
ebola
mer
coronaviru
outbreak
west
africa
saudi
arabia
respect
regard
intens
research
mechan
first
step
viral
emerg
develop
author
declar
compet
financi
interest
